Rewalk Robotics (NASDAQ:RWLK) was downgraded by equities research analysts at ValuEngine from a “buy” rating to a “hold” rating in a research report issued to clients and investors on Wednesday, May 1st, ValuEngine reports.

Separately, HC Wainwright reiterated a “neutral” rating on shares of Rewalk Robotics in a report on Friday, March 15th.

Rewalk Robotics stock opened at $2.54 on Wednesday. The company has a debt-to-equity ratio of 3.50, a current ratio of 1.84 and a quick ratio of 1.50. Rewalk Robotics has a 1-year low of $2.46 and a 1-year high of $33.75.

Rewalk Robotics (NASDAQ:RWLK) last released its quarterly earnings results on Tuesday, May 7th. The medical device company reported ($1.25) earnings per share for the quarter, missing analysts’ consensus estimates of ($1.00) by ($0.25). The firm had revenue of $1.58 million for the quarter, compared to analyst estimates of $1.62 million. As a group, research analysts forecast that Rewalk Robotics will post -2.41 earnings per share for the current year.

A hedge fund recently bought a new stake in Rewalk Robotics stock. Geode Capital Management LLC bought a new position in Rewalk Robotics Ltd (NASDAQ:RWLK) during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm bought 284,311 shares of the medical device company’s stock, valued at approximately $49,000. Geode Capital Management LLC owned 0.39% of Rewalk Robotics at the end of the most recent reporting period.

About Rewalk Robotics

ReWalk Robotics Ltd., a medical device company, designs, develops, and commercializes exoskeletons for wheelchair-bound individuals with mobility impairments or other medical conditions. The company offers ReWalk Personal for everyday use to paraplegic individuals at home and in their communities; and ReWalk Rehabilitation for exercise and therapy used in hospitals and rehabilitation centers in the United States and Europe.

See Also: How does equity income fit into an investing strategy?

To view ValuEngine’s full report, visit ValuEngine’s official website.

Receive News & Ratings for Rewalk Robotics Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for Rewalk Robotics and related companies with MarketBeat.com’s FREE daily email newsletter.


Source link